facts and figures on euthanasia and pas · 2016-06-07 · •euthanasia: 4% of total number of...
TRANSCRIPT
Annemieke Horikx,
Pharmacist, KNMP
Facts and figures
on euthanasia
and PASThe practice in the Netherlands
Nothing to disclose
Non-approved use
• Thiopental, mixtura nontherapeutica (seco- or pentobarbiturate), anti-emetics, neuromuscularblockers (rocuronium, atracurium, cisatracurium)
• Injection, infusion, elastomeric pump
Disclose
• Euthanasia: 4% of total number of deaths
• Database of more than 5000 recordsfrom 1998-2015
• First presentation of the 2013-2015 data(3000 records)
Practice in the Netherlands
• Development of the Guideline in the Netherlands
• Method
• Questionnaires
• Facts and figuresResults of implementation practice
Note: the period analysed, is the period 2013 - 2015If it is different, I tell you on the slide
Topics
Publisher Year
Stafleu 1977 P. Admiraal – Report about euthanasia in hospital
NVVE (Dignity in DyingThe Netherlands)
1980 Brochure Responsible Euthanasia
KNMP (Dutch Pharmacists Association)
1987 Technical report Euthanasia
KNMP 1994 Euthanasia in practice and constitution of the euthanatic agents
KNMP 1998 Euthanasia in practice and constitution of the euthanatic agents
KNMP 2007 Standard Euthanasia
KNMG (physiciansassociation)/KNMP
2012 Guideline for the practice of Euthanasia and Physician-Assisted Suicide
Development of the guideline
Guideline 2012
• Development of the Guideline in the Netherlands
• Method
• Questionnaires
• Facts and figuresResults of implementation practice
Note: the period analysed, is the period 2013 - 2015If it is different, I tell you on the slide
Topics
• Coma-inductorthiopental 2 grams or propofol 1 gram
• Check deep coma
• Neuromusculair blockerrocuronium 150 mg or atracurium 100 mg or cisatracurium 30 mg
Euthanasia - Intravenous method
• Thiopental 2 grams (prior 1.5 grams)
• Propofol added as coma induction medication
• Elastomeric pump as intravenous administration
Differences current and previous guideline – intravenous method
Elastomeric pump
• Premedication:Start anti-emetic 12 hours in advance.
• Mixtura Nontherapeutica 100 ml15 grams pento- or secobarbital sodium
Physician-Assisted-Suicide (PAS)oral method
• Barbiturate 15 grams (prior 9 grams)
• Advise on when to use the oral method
• Agreement about when to use the IV method in addition to the oral method
• Use of elastomeric pump in case patient wishes to be in control
Differences current and previous guideline – oral method
• Development of the Guideline in the Netherlands
• Method
• Questionnaires
• Facts and figuresResults of implementation practice
Note: the period analysed, is the period 2013 - 2015If it is different, I tell you on the slide
Topics
• Physicians: since 1987• Pharmacists: since 1998• On voluntary basis • Anonymous
• Objective: to improve the guideline
NOT to check whether the procedure has been carried out correctly
Questionnaires
• Patient details (age, underlying disease)• Method used• Location of the procedure• Problems and symptoms experienced during
procedure• Communication and cooperation physician
and pharmacist• Suggestions for improving the guideline
What kind of questions?
Questionnaires returned
• Development of the Guideline in the Netherlands
• Method
• Questionnaires
• Facts and figuresResults of implementation practice
Note: the periode analysed, is the period 2013 - 2015If it is different, I tell you on the slide
Topics
Underlying disease2015 (n=1000)
Methods 1998-2015
Location of euthanasia procedure(n=3000)
Location of euthanasia procedure andmethods (n=3000)
Underlying disease and method used(n= 3000)
Focus on the oral method
Shift oral method to pump
Decision to use oral methodn=163
Underlying disease andchoice for oral method (n=3000)
Time lapse betweeningesting and dying
Symptoms Numbers
Physcian observation
Retching 9
Snoring 3
Asleep before finishing the 100 ml drink 3
Muscle contraction 2
Some return of vital functions 2
Patient comment/remark
Bad taste 3
Pain in throat 1
Pain in stomach 1
Heat sensation 1
What did the physician / patientnotice?
Intravenous (IV) in addition to the oralmethod
Communication and cooperation pharmacist and physician
• 93% discussed the guidelinetogether
• 7% did not discussed the guideline together
Reasons for not discussing: - General practitioner has his own pharmacy- Physician and pharmacist recently discussed the guideline
Communication and cooperation before the procedure
• Evaluation of the technical aspects
• Return of unused life-ending agents
• Experiences of the patient and next of kin
• Reflection and closure of the cooperativetrajectory
Communication and cooperation after procedure
Return of unused life-ending agents
• The barbiturate drink is used less and is partly replacedby elastomeric pump
• Due to the improved screening of patients and/or theincreased dosage barbiturate, more patients die within 30 min
• The recommendation, that physicians and pharmacists take sufficient time afterwards for face tot face evaluation of the complete trajectory
Take-home message
English version of the Guideline is available on www.knmp.nl or www.knmg.nl(search for ‘guideline euthanasia’)
For more information contact [email protected]
Thank you for your attention